Adult and Pediatric Hemoconcentrators Market Synopsis
Adult and Pediatric Hemoconcentrators market size was valued at USD 3.85 Billion in 2023, and is Projected to Reach USD 7.3 Billion by 2032, Growing at a CAGR of 7.36% From 2024-2032.
Adult and Pediatric Hemoconcentrators Market refers to products that are used to filter blood components and specifically limit the abundance of water and electrolytes in a patient’s blood. These devices are employed in cardiovascular and surgical operations to meter the respective patient’s fluids and minimize blood transfusions. They play an essential role in handling patient care during CPB activities and other extensive surgeries; they cater for all categories of patients, included both the adult and the children with some additional features due to their physiological differences.
- The market for adult and pediatric hemoconcentrators is also advancing in the international market for hemoconcentrators due to a constant rise in cardiovascular diseases and an annual growth in surgical operations. Hemoconcentrators play a critical role within surgical procedures particularly those that involve CPB in order to effect patient blood volume thereby minimizing the use of donor blood. This trend falls in line with the increase in the desire to advance in surgical procedures reducing the occurrences of complications after surgery. Since the use of hemoconcentrators has widened significantly across developed and developing regions in connection with the numerous operations of cardiac surgery, improved health care structures and enhanced technology have fortunately boosted the demand for hemoconcentrators in the market.
- According to research, the market has been segmented according to the type of product, and application which include adult and pediatric segments. Known application in paediatric patients of congenital heart disease; mainly patients need to use some hemoconcentrators due to small volume of blood and particular rate of blood circulation. The demand in pediatric hemoconcentrators is also increasing since it now becomes easier to treat children for various cardiovascular surgeries. However, the adult segment maintains the largest share with continued and high demand arising from growing instances of cardiovascular ailments, population aging, and proliferation of heart surgeries launched in emerging countries.
Adult and Pediatric Hemoconcentrators Market Trend Analysis
Technological Innovations Elevating Market Growth
- Technological advancement can be classified under the major growth strategy that is revolutionising the Adult and Pediatric Hemoconcentrators Market and improving the quality of patient care as well as efficiency of the product. Two more recent innovations are the improvements of fiber membrane filtration efficiency and the creation of compact and light structures that allow easier manipulation during surgery. These innovations increase the potentiality of hemoconcentrators in minimizing diffusion of blood which is vital in preservation of volume in surgical patient. Moreover, the developments in the filter processes in order to prevent the increased chances of getting infected or having the equipment contaminated, extend the safety and efficiency of these devices and making them more suitable for the patients.
- Furthermore, the ideal is that the industry cares about as recognizing as many specific requirements of children as possible and it focuses on developing dedicated innovations. The interventions applied in the process of enhancing the technology for controlling the flow of small volumes of the blood, as well as the measures that address the problem of mincing volumes, are designed for pediatric patients exclusively. Addressing these crucial care issues, the manufacturers are improving the safety and efficacy of hemoconcentrators specifically designed for pediatric patients. It not only supports the market in gaining the approval of different healthcare centres, but also puts those manufacturers in a vantages area in meeting the increasing demand for safer and more flexible hemoconcentrators from multiple types of patients, which in turn, fuels the market’s growth.
Rising Cardiovascular Surgeries in Emerging Markets
- New geographies are another unexplored opportunity in the Adult and Pediatric Hemoconcentrators Market because of the increasing prevalence of CVDs and a boost in the number of surgeries. Emerging economies including Asia-Pacific and Latin America having Life Sciences industries developing fast making it easier to access such advanced procedures not attainable by the less developed markets. The rise in needs for cardiovascular health awareness is the key contributor to this growth because it creates demand in effective surgical solutions. Since these regions are devising strategies to improve the efficiency and quality of their respective healthcare sectors, the usage of improving technologies like hemoconcentrators should experience an upward trend in order to yield better patient results as well as succeed in operations.
- Also, based on the emphasis by governments on healthcare enhancement, key opportunity in market growth seems to be apparent in pediatric cardiac surgeries which require hemoconcentrators to reduce risk factors. This makes the environment very appealing to manufacturers who seek to invest in these markets and actively participate in partnership and localization of the products as per individual patient profiles. In light of these market features, manufacturers have an opportunity to provide improved and specialized products and services to address issues faced in emerging markets, therefore gaining a competitive edge in a continually expanding market, with promising future growth while responding to the need for enhancing the quality of healthcare for both adult and pediatric patients.
Adult and Pediatric Hemoconcentrators Market Segment Analysis:
Adult and Pediatric Hemoconcentrators Market is segmented on the basis of type, application and end user.
By Type, Adult Hemoconcentrators segment is expected to dominate the market during the forecast period
- The Adult Hemoconcentrators segment deals with the delivery of customized hemocompromised surgery for adults who require surgery for different CPP & other critical procedures. These devices are designed to process more blood volume and have the best filtration feature to boost its effectiveness in concentrating the red blood cell from universal donor blood in different surgeries. The demand for adult hemoconcentrators is still high in light of rising cardiovascular diseases prevalence, surgeries number and the quest for patients’ better outcomes in healthcare facilities.
- On the other hand, Pediatric Hemoconcentrators are developed specifically for pediatric patient population, and meet all the physiological needs of children and infants. These devices are targeted towards the regulation of this decimals and management of the otherwise small blood volumes needed in surgeries as well as the control of blood concentration levels. Advancements in hemoconcentrators for children centre on safety aspects which include smaller priming volumes; material that is least reactive with patients’ blood. The demand for the pediatric hemoconcentrators is growing due to the knowledge satisfaction of the healthcare providers about the improvement of the pediatric patients’ care quality and the progress in the surgery, which is made possible by the addition of specialized medical devices in pediatric cardiac surgery.
By Application, Neurosurgery segment expected to held the largest share
- The trends in market share of Adult and Pediatric Hemoconcentrators are highly dependent on the usage of hemoconcentrators in different specialties of surgery, with cardiac surgery leading the pack. NEW Hemoconcentrators provide important support in mediastinal surgical procedures such as cardiopulmonary bypass, where blood volume and concentration must be controlled for the outcome to be satisfactory. Centrifugation also allows for the matching of plasma and red blood cells in relation to the affected persons’ concentration and other putative beneficiaries; thus minimize on the use of blood transfusion hence its risks. Cardiovascular diseases occur frequently and require more frequent heart surgeries, which create strong and consistent demand for hemoconcentrators in this specialty and show how they contribute to improving patient outcomes during difficult cardiovascular procedures.
- In addition to the cardiac surgery, hemoconcentrators are used more often in orthopedic surgery, neurosurgical operations, general operations and other surgeries. For example, in orthopedic operations, these gadgets help control bleeding and stabilise circulation in tough operations like joint replacement operations. Likewise, in neurosurgery where blood management is most sensitive, hemoconcentrators assist in attaining among the best patient results because of smooth blood concentration. The applicability of hemoconcentrators in a wide range of surgical procedures not only increases its market potential, but also the significance of these in the enhancement of surgical processes and safety requirements of patients in a broad spectrum of specialties. It is further estimated that as new applications of surgery are developed and enhanced applications are adopted, hemoconcentrators will on a similar trend weigh the characterization across these imperative segments.
Adult and Pediatric Hemoconcentrators Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- In 2023, North America continued to emerge as the largest geographical market of adult and pediatric hemoconcentrators, majorly due to increased focus on Fine Health Sector of United State and Canada together within the area of cardiovascular surgery. This region rules about 40-45% global market and its demand for sophisticated medical devices that improve the effectiveness of surgery and patient safety is growing fast. The enhanced investment in healthcare technology has helped the manufacturer and deploy new devices to reach the target of healthcare providers to meet arising demands of patients ensuing from complicated surgeries. Further, the North American region has a strong foundation when it comes to healthcare and implementation of necessary medical technologies, thereby booster for the market types.
- An increased incidence of cardiovascular diseases in North America and a continually increasing pool of the ageing population has led to the need for hemoconcentrators. This demographic change leads to more individuals developing some form of cardiovascular illness that would necessitate surgical intervention; this is where efficient blood management solutions are critical. Additionally, well-established industry players operating in this region ensure relentless research hence extending their innovations to produce products that suit the need of adults and children patients alike. Hemoconcentrators market to grow in North America, as manufacturers continue to develop better devices and improve safety given increased healthcare system focus on adapted patient needs.
Active Key Players in the Adult and Pediatric Hemoconcentrators Market
- Aesculap, Inc. (Germany)
- Asahi Kasei Corporation (Japan)
- Braile Biomedical (Brazil)
- Edwards Lifesciences Corporation (United States)
- Eurosets S.r.l. (Italy)
- Getinge AB (Sweden)
- Jostra AG (Germany)
- Kawasumi Laboratories, Inc. (Japan)
- LivaNova PLC (United Kingdom)
- Medtronic plc (Ireland)
- Nipro Corporation (Japan)
- Sorin Group (Italy)
- Terumo Cardiovascular Systems Corporation (United States)
- Vitalmex S.A. de C.V. (Mexico)
- Wego Group Co., Ltd. (China), Other key Players.
Global Adult and Pediatric Hemoconcentrators Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 3.85 Billion |
Forecast Period 2024-32 CAGR: |
7.36 % |
Market Size in 2032: |
USD 7.3 Billion |
Segments Covered: |
By Type |
|
|
By Application |
|
||
By End User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Adult and Pediatric Hemoconcentrators Market by Product Type
4.1 Adult and Pediatric Hemoconcentrators Market Snapshot and Growth Engine
4.2 Adult and Pediatric Hemoconcentrators Market Overview
4.3 Adult Hemoconcentrators
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Adult Hemoconcentrators: Geographic Segmentation Analysis
4.4 Pediatric Hemoconcentrators
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Pediatric Hemoconcentrators: Geographic Segmentation Analysis
Chapter 5: Adult and Pediatric Hemoconcentrators Market by Application
5.1 Adult and Pediatric Hemoconcentrators Market Snapshot and Growth Engine
5.2 Adult and Pediatric Hemoconcentrators Market Overview
5.3 Cardiac Surgery
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Cardiac Surgery: Geographic Segmentation Analysis
5.4 Orthopedic Surgery
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Orthopedic Surgery: Geographic Segmentation Analysis
5.5 Neurosurgery
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Neurosurgery: Geographic Segmentation Analysis
5.6 General Surgery
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 General Surgery: Geographic Segmentation Analysis
5.7 Other
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Other : Geographic Segmentation Analysis
Chapter 6: Adult and Pediatric Hemoconcentrators Market by End User
6.1 Adult and Pediatric Hemoconcentrators Market Snapshot and Growth Engine
6.2 Adult and Pediatric Hemoconcentrators Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation Analysis
6.4 Ambulatory Surgical Centers
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Ambulatory Surgical Centers: Geographic Segmentation Analysis
6.5 Specialty Clinics
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Specialty Clinics: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Adult and Pediatric Hemoconcentrators Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 AESCULAP INC (GERMANY)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 ASAHI KASEI CORPORATION (JAPAN)
7.4 BRAILE BIOMEDICAL (BRAZIL)
7.5 EDWARDS LIFESCIENCES CORPORATION (UNITED STATES)
7.6 EUROSETS SRL (ITALY)
7.7 GETINGE AB (SWEDEN)
7.8 JOSTRA AG (GERMANY)
7.9 KAWASUMI LABORATORIES INC (JAPAN)
7.10 LIVANOVA PLC (UNITED KINGDOM)
7.11 MEDTRONIC PLC (IRELAND)
7.12 NIPRO CORPORATION (JAPAN)
7.13 SORIN GROUP (ITALY)
7.14 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION (UNITED STATES)
7.15 VITALMEX SA DE CV (MEXICO)
7.16 WEGO GROUP CO LTD (CHINA)
7.17 OTHER KEY PLAYERS
Chapter 8: Global Adult and Pediatric Hemoconcentrators Market By Region
8.1 Overview
8.2. North America Adult and Pediatric Hemoconcentrators Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Product Type
8.2.4.1 Adult Hemoconcentrators
8.2.4.2 Pediatric Hemoconcentrators
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Cardiac Surgery
8.2.5.2 Orthopedic Surgery
8.2.5.3 Neurosurgery
8.2.5.4 General Surgery
8.2.5.5 Other
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals
8.2.6.2 Ambulatory Surgical Centers
8.2.6.3 Specialty Clinics
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Adult and Pediatric Hemoconcentrators Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Product Type
8.3.4.1 Adult Hemoconcentrators
8.3.4.2 Pediatric Hemoconcentrators
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Cardiac Surgery
8.3.5.2 Orthopedic Surgery
8.3.5.3 Neurosurgery
8.3.5.4 General Surgery
8.3.5.5 Other
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals
8.3.6.2 Ambulatory Surgical Centers
8.3.6.3 Specialty Clinics
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Bulgaria
8.3.7.2 The Czech Republic
8.3.7.3 Hungary
8.3.7.4 Poland
8.3.7.5 Romania
8.3.7.6 Rest of Eastern Europe
8.4. Western Europe Adult and Pediatric Hemoconcentrators Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Product Type
8.4.4.1 Adult Hemoconcentrators
8.4.4.2 Pediatric Hemoconcentrators
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Cardiac Surgery
8.4.5.2 Orthopedic Surgery
8.4.5.3 Neurosurgery
8.4.5.4 General Surgery
8.4.5.5 Other
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals
8.4.6.2 Ambulatory Surgical Centers
8.4.6.3 Specialty Clinics
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 Netherlands
8.4.7.5 Italy
8.4.7.6 Russia
8.4.7.7 Spain
8.4.7.8 Rest of Western Europe
8.5. Asia Pacific Adult and Pediatric Hemoconcentrators Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Product Type
8.5.4.1 Adult Hemoconcentrators
8.5.4.2 Pediatric Hemoconcentrators
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Cardiac Surgery
8.5.5.2 Orthopedic Surgery
8.5.5.3 Neurosurgery
8.5.5.4 General Surgery
8.5.5.5 Other
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals
8.5.6.2 Ambulatory Surgical Centers
8.5.6.3 Specialty Clinics
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Adult and Pediatric Hemoconcentrators Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Product Type
8.6.4.1 Adult Hemoconcentrators
8.6.4.2 Pediatric Hemoconcentrators
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Cardiac Surgery
8.6.5.2 Orthopedic Surgery
8.6.5.3 Neurosurgery
8.6.5.4 General Surgery
8.6.5.5 Other
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals
8.6.6.2 Ambulatory Surgical Centers
8.6.6.3 Specialty Clinics
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkey
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Adult and Pediatric Hemoconcentrators Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Product Type
8.7.4.1 Adult Hemoconcentrators
8.7.4.2 Pediatric Hemoconcentrators
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Cardiac Surgery
8.7.5.2 Orthopedic Surgery
8.7.5.3 Neurosurgery
8.7.5.4 General Surgery
8.7.5.5 Other
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals
8.7.6.2 Ambulatory Surgical Centers
8.7.6.3 Specialty Clinics
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Global Adult and Pediatric Hemoconcentrators Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 3.85 Billion |
Forecast Period 2024-32 CAGR: |
7.36 % |
Market Size in 2032: |
USD 7.3 Billion |
Segments Covered: |
By Type |
|
|
By Application |
|
||
By End User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Frequently Asked Questions :
The forecast period in the Adult and Pediatric Hemoconcentrators Market research report is 2024-2032.
Sample key players: Aesculap, Inc., Asahi Kasei Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Medtronic plc
The Adult and Pediatric Hemoconcentrators Market is segmented into Type, Application, End User and region. By Type, the market is categorized into Adult Hemoconcentrators, Pediatric Hemoconcentrators, By Application, the market is categorized into Cardiac Surgery, Orthopedic Surgery, Neurosurgery, General Surgery, Other Surgical Procedures. By End User, the market is categorized into Hospitals, Ambulatory Surgical Centers, Specialty Clinics. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
Adult and Pediatric Hemoconcentrators Market refers to products that are used to filter blood components and specifically limit the abundance of water and electrolytes in a patient’s blood. These devices are employed in cardiovascular and surgical operations to meter the respective patient’s fluids and minimize blood transfusions. They play an essential role in handling patient care during CPB activities and other extensive surgeries; they cater for all categories of patients, included both the adult and the children with some additional features due to their physiological differences.
Adult and Pediatric Hemoconcentrators Market Size Was Valued at USD 3.85 Billion in 2023, and is Projected to Reach USD 7.3 Billion by 2032, Growing at a CAGR of 7.36% From 2024-2032.